Product Code: GVR-1-68038-818-3
Omega 3 Supplements Market Growth & Trends:
The global omega 3 supplements market size is expected to reach USD 12.89 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.1% from 2025 to 2030. The demand for omega-3 supplements is projected to be driven by the growing adoption of the product to fulfill the daily nutritional requirements and maintain optimum health of organs by the geriatric population in developed economies, such as the U.S., Canada, the U.K., and France.
Furthermore, the outbreak of COVID-19 from the beginning of 2020 led to increased consumer awareness regarding the significance of immunity and immunity-boosting products, which is expected to fuel the demand for various omega fatty acids products. Increasing incorporation of products in gummies form with novel flavor is expected to increase product penetration among children in the coming years.
Docosahexaenoic acid (DHA) is an omega-3 fatty acid comprising over 93.0% of omega-3 fats in the retina and 97.0% in the human brain. Rising demand for DHA supplements for pregnant ladies owing to lack of adequate DHA in the diet is expected to drive the market. Additionally, increasing demand for omega-3 DHA-rich supplements from non-lactating mothers is expected to propel the product demand over the forecast period.
Rising chronic diseases such as strokes, arthritis, coronary heart diseases, and cancer are expected to propel the demand for omega 3 supplements over the upcoming years. According to the World Health Organization (WHO), over 14 million people between the ages of 30 and 70 die every year due to distinguished chronic diseases. Rising government support to provide consumers with low-cost preventive drugs is projected to propel the demand for omega 3 supplements over the forecast period.
Omega 3 Supplements Market Report Highlights:
- In terms of source, the krill oil-based omega 3 supplements are projected to expand at the fastest CAGR over the projected period on account of the growing demand for eicosapentaenoic acid (EPA) and DHA-based supplements among consumers globally
- On the basis of functionality, The cardiovascular health segment dominated the market with the largest revenue share in 2024. The growing prevalence of cardiovascular diseases as a result of the slow and inactive lifestyle, especially in the age group of 30 to 40 years, and fluctuating dietary patterns are anticipated to spur the segment growth over the next few years
- The market in China is expected to witness significant growth over the upcoming years owing to the propelling spending capacity of consumers. Easy online availability of these supplements in the country has also strengthened its demand in the country
- Strong mass channels of distribution, online sales, and a growing number of standalone mass facing brands by several companies, including Optimum Nutrition; Herbalife International of America, Inc.; Now Foods., and Amway are the key factors expected to fuel the demand for fish oil-based omega 3 supplements over the upcoming years
- In September 2020, Aker BioMarine launched a new support vessel at Yantai yard, China. The new vessel's launching has assured the stakeholders that the lockdown due to the COVID-19 pandemic has not affected the company
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Omega 3 Supplements Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related Market Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Profit Margin Analysis (Industry-level)
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Market Opportunities
- 3.3.4. Market Challenges
- 3.4. Industry Analysis Tools
- 3.4.1. Porter's Five Forces Analysis
- 3.5. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
- 4.1. Demographic Analysis
- 4.2. Consumer Trends and Preferences
- 4.3. Factors Affecting Buying Decision
- 4.4. Consumer Product Adoption
- 4.5. Observations & Recommendations
Chapter 5. Omega 3 Supplements Market: Source Estimates & Trend Analysis
- 5.1. Omega 3 Supplements Market, By Source: Key Takeaways
- 5.2. Source Movement Analysis & Market Share, 2024 & 2030
- 5.3. Market Estimates & Forecasts, By Source, 2018 - 2030 (USD Million)
- 5.3.1. Fish Oil
- 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.2. Krill Oil
- 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.3. Algal Oil
- 5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.4. Others
- 5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Omega 3 Supplements Market: Form Estimates & Trend Analysis
- 6.1. Omega 3 Supplements Market, By Form: Key Takeaways
- 6.2. Form Movement Analysis & Market Share, 2024 & 2030
- 6.3. Market Estimates & Forecasts, By Form, 2018 - 2030 (USD Million)
- 6.3.1. Tablets
- 6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.2. Capsules
- 6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3. Soft Gels
- 6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.4. Others
- 6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Omega 3 Supplements Market: Functionality Estimates & Trend Analysis
- 7.1. Omega 3 Supplements Market, By Functionality: Key Takeaways
- 7.2. Functionality Movement Analysis & Market Share, 2024 & 2030
- 7.3. Market Estimates & Forecasts, By Functionality, 2018 - 2030 (USD Million)
- 7.3.1. Cardiovascular Health
- 7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.2. Brain, Nervous System & Mental Health
- 7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3. Eye Diseases
- 7.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.4. Diabetes
- 7.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.5. Others
- 7.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Omega 3 Supplements Market: End Use Estimates & Trend Analysis
- 8.1. Omega 3 Supplements Market, By End Use: Key Takeaways
- 8.2. End Use Movement Analysis & Market Share, 2024 & 2030
- 8.3. Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
- 8.3.1. Adults
- 8.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.3.2. Geriatric
- 8.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.3.3. Pregnant Woman
- 8.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.3.4. Children
- 8.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 8.3.5. Infants
- 8.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 9. Omega 3 Supplements Market: Distribution Channel Estimates & Trend Analysis
- 9.1. Omega 3 Supplements Market, By Distribution Channel: Key Takeaways
- 9.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
- 9.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
- 9.3.1. OTC
- 9.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 9.3.1.2. Supermarkets/ Hypermarkets/Food Stores
- 9.3.1.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 9.3.1.3. Drug Stores & Pharmacies
- 9.3.1.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 9.3.1.4. Online Retailers
- 9.3.1.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 9.3.1.5. Others
- 9.3.1.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 9.3.2. Prescribed
- 9.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 10. Omega 3 Supplements Market: Regional Estimates & Trend Analysis
- 10.1. Omega 3 Supplements Market: Regional Outlook
- 10.2. Regional Marketplaces: Key Takeaways
- 10.3. Market Estimates & Forecasts, by Region, 2018 - 2030 (USD Million)
- 10.3.1. North America
- 10.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.1.2. U.S.
- 10.3.1.2.1. Key country dynamics
- 10.3.1.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.1.3. Canada
- 10.3.1.3.1. Key country dynamics
- 10.3.1.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.1.4. Mexico
- 10.3.1.4.1. Key country dynamics
- 10.3.1.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.2. Europe
- 10.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.2.2. UK
- 10.3.2.2.1. Key country dynamics
- 10.3.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.2.3. Germany
- 10.3.2.3.1. Key country dynamics
- 10.3.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.2.4. France
- 10.3.2.4.1. Key country dynamics
- 10.3.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.2.5. Italy
- 10.3.2.5.1. Key country dynamics
- 10.3.2.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.2.6. Spain
- 10.3.2.6.1. Key country dynamics
- 10.3.2.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.2.7. Norway
- 10.3.2.7.1. Key country dynamics
- 10.3.2.7.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.2.8. Netherlands
- 10.3.2.8.1. Key country dynamics
- 10.3.2.8.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.3. Asia Pacific
- 10.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.3.2. China
- 10.3.3.2.1. Key country dynamics
- 10.3.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.3.3. India
- 10.3.3.3.1. Key country dynamics
- 10.3.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.3.4. Japan
- 10.3.3.4.1. Key country dynamics
- 10.3.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.3.5. Australia
- 10.3.3.5.1. Key country dynamics
- 10.3.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.3.6. New Zealand
- 10.3.3.6.1. Key country dynamics
- 10.3.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.4. Latin America
- 10.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.4.2. Brazil
- 10.3.4.2.1. Key country dynamics
- 10.3.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.4.3. Argentina
- 10.3.4.3.1. Key country dynamics
- 10.3.4.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.5. Middle East & Africa
- 10.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 10.3.5.2. UAE
- 10.3.5.2.1. Key country dynamics
- 10.3.5.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 11. Omega 3 Supplements Market: Competitive Analysis
- 11.1. Recent Developments & Impact Analysis, by Key Market Participants
- 11.2. Company Categorization
- 11.3. Participant's Overview
- 11.4. Financial Performance
- 11.5. Product Benchmarking
- 11.6. Company Market Share Analysis, 2024 (%)
- 11.7. Company Heat Map Analysis
- 11.8. Strategy Mapping
- 11.9. Company Profiles
- 11.9.1. Nordic Naturals
- 11.9.1.1. Company Overview
- 11.9.1.2. Financial Performance
- 11.9.1.3. Product Portfolios
- 11.9.1.4. Strategic Initiatives
- 11.9.2. NutriGold
- 11.9.2.1. Company Overview
- 11.9.2.2. Financial Performance
- 11.9.2.3. Product Portfolios
- 11.9.2.4. Strategic Initiatives
- 11.9.3. Reckitt Benckiser Group PLC
- 11.9.3.1. Company Overview
- 11.9.3.2. Financial Performance
- 11.9.3.3. Product Portfolios
- 11.9.3.4. Strategic Initiatives
- 11.9.4. Pharma Nord Inc.
- 11.9.4.1. Company Overview
- 11.9.4.2. Financial Performance
- 11.9.4.3. Product Portfolios
- 11.9.4.4. Strategic Initiatives
- 11.9.5. i-Health, Inc.
- 11.9.5.1. Company Overview
- 11.9.5.2. Financial Performance
- 11.9.5.3. Product Portfolios
- 11.9.5.4. Strategic Initiatives
- 11.9.6. AKER BIOMARINE
- 11.9.6.1. Company Overview
- 11.9.6.2. Financial Performance
- 11.9.6.3. Product Portfolios
- 11.9.6.4. Strategic Initiatives
- 11.9.7. Luhua Biomarine (Shandong) Co., Ltd
- 11.9.7.1. Company Overview
- 11.9.7.2. Financial Performance
- 11.9.7.3. Product Portfolios
- 11.9.7.4. Strategic Initiatives
- 11.9.8. Pharmavite
- 11.9.8.1. Company Overview
- 11.9.8.2. Financial Performance
- 11.9.8.3. Product Portfolios
- 11.9.8.4. Strategic Initiatives
- 11.9.9. KD Pharma Group SA
- 11.9.9.1. Company Overview
- 11.9.9.2. Financial Performance
- 11.9.9.3. Product Portfolios
- 11.9.9.4. Strategic Initiatives
- 11.9.10. NOW Foods
- 11.9.10.1. Company Overview
- 11.9.10.2. Financial Performance
- 11.9.10.3. Product Portfolios
- 11.9.10.4. Strategic Initiatives
- 11.9.11. GSK plc
- 11.9.11.1. Company Overview
- 11.9.11.2. Financial Performance
- 11.9.11.3. Product Portfolios
- 11.9.11.4. Strategic Initiatives
- 11.9.12. Nature's Bounty
- 11.9.12.1. Company Overview
- 11.9.12.2. Financial Performance
- 11.9.12.3. Product Portfolios
- 11.9.12.4. Strategic Initiatives